Improvement of neuro-degeneration in a multiple system atrophy animal model by human bone marrow-derived mesenchymal stem cells

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: HWANG, Chul Ju (Chungbuk National University, Cheongju, Korea, Republic Of)
  • Co-author(s): Chul Ju Hwang:
    Mi Hee Park: Chungbuk National University, Cheongju, Korea, Republic Of
    In Jun Yeo: Chungbuk National University, Cheongju, Korea, Republic Of
    Dong-Young Choi: Yeungnam University, Gyeongsan, Korea, Republic Of
    Pil-Hoon Park: Yeungnam University, Gyeongsan, Korea, Republic Of
    Hyung Sook Kim: Corestem Inc, Seongnam, Korea, Republic Of
    Jung Tae Lee: Corestem Inc, Seongnam, Korea, Republic Of
    Young Suk Jung: Pusan National University, Busan, Korea, Republic Of
    Sang-Bae Han: Chungbuk National University, Cheongju, Korea, Republic Of
    Jin Tae Hong: Chungbuk National University, Cheongju, Korea, Republic Of
  • Abstract:

    Background

    Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder of unknown etiology, but is closely associated with dopaminergic neuro damage. MSA progression is rapid; hence, long-term drug treatments do not have any therapeutic benefit. 

    Purpose

    Mesenchymal stem cells (MSCs) were recently found to improve functional recovery in..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login